Emerging Collaboration in EU Drug Pricing and Reimbursement Table 2

The Regeneron SVP details the company’s approach to reaching oncology patients across the planet.

The chaotic tariff situation is forcing pharma companies to prepare for multiple outcomes.

While supply chain interruptions are a strong possibility, the tariffs also provide the industry with a chance to improve certain conditions.

Four tips for midsized companies when entering new global markets.

The pharmaceutical company had previously been subjected to a 2-year suspension.

Pharma companies face unique challenges with market access in this region.